Market Quick Review | Core CPI rose 0.6% year-on-year in September. Insufficient effective demand is still a restriction on the economic endogenous recovery
North China Pharmaceuticals' centralized procurement of selected products is punished for interruption of supply. Joint procurement office: The bid must be fulfilled
The valuation rose by 432% in three months. Jianshi Technology, which will be listed on Hong Kong stocks, has begun to prepare for A-share listing | IPO Express